Show simple item record

AuthorDatta, Saptashwa
AuthorRajnish, K Narayanan
AuthorGeorge Priya Doss, C
AuthorMelvin Samuel, S
AuthorSelvarajan, E
AuthorZayed, Hatem
Available date2020-07-20T06:15:28Z
Publication Date2020-07-01
Publication NameExpert Opinion on Biological Therapy
Identifierhttp://dx.doi.org/10.1080/14712598.2020.1787980
CitationSaptashwa Datta , K Narayanan Rajnish , C George Priya Doss , S. Melvin Samuel , E. Selvarajan & Hatem Zayed (2020): Enzyme therapy: a forerunner in catalyzing a healthy society?, Expert Opinion on Biological Therapy, DOI: 10.1080/14712598.2020.1787980
ISSN1471-2598
URIhttp://hdl.handle.net/10576/15297
AbstractThe use of enzymes in various industries has been prevalent for centuries. However, their potency as therapeutics remained latent until the late 1950 s, when scientists finally realized the gold mine they were sitting on. Enzyme therapy has seen rapid development over the past few decades and has been widely used for the therapy of myriad diseases, including lysosomal storage disorders, cancer, Alzheimer's disease, irritable bowel syndrome, exocrine pancreatic insufficiency, and hyperuricemia. Enzymes are also used for wound healing, the treatment of microbial infections, and gene therapy. This is a comprehensive review of the therapeutic use of enzymes that can act as a guidepost for researchers and academicians and presents a general overview of the developments in enzyme therapy over the years, along with updates on recent advancements in enzyme therapy research. Although enzyme therapy is immensely beneficial and induces little auxiliary damage, it has several drawbacks, ranging from high cost, low stability, low production, and hyperimmune responses to the failure to cure a variety of the problems associated with a disease. Further fine-tuning and additional clinical efficacy studies are required to establish enzyme therapy as a forerunner to catalyzing a healthy society.
Languageen
PublisherTaylor & Francis
SubjectAlzheimer’s disease
Enzyme therapy
cancer
exocrine pancreatic insufficiency
gene therapy
irritable bowel syndrome
lysosomal storage disorders
TitleEnzyme therapy: a forerunner in catalyzing a healthy society?
TypeArticle
ESSN1744-7682
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record